Skip to main content
. 2017 Mar 10;8(22):35718–35727. doi: 10.18632/oncotarget.16082

Figure 2. Alterations of salivary glycopatterns between patients with GC or AG and HV.

Figure 2

(A) The difference of salivary glycopatterns between HV and GC&AG. (B) The difference of salivary glycopatterns between AG and HV&GC. (C) The difference of salivary glycopatterns between GC and HV&AG. (D) The scatterplots of Spearman's correlation between pathological type and specific lectins. *P < 0.05; **P < 0.01; and ***P < 0.001.